Pal, R., Banerjee, M., Mukherjee, S., Bhogal, R. S., Kaur, A., & Bhadada, S. K. (2021). Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: An updated systematic review and meta-analysis. Ther Adv Endocrinol Metab.
Chicago-stil citatPal, Rimesh, Mainak Banerjee, Soham Mukherjee, Ranjitpal Singh Bhogal, Amanpreet Kaur, och Sanjay K. Bhadada. "Dipeptidyl Peptidase-4 Inhibitor Use and Mortality in COVID-19 Patients With Diabetes Mellitus: An Updated Systematic Review and Meta-analysis." Ther Adv Endocrinol Metab 2021.
MLA-referensPal, Rimesh, et al. "Dipeptidyl Peptidase-4 Inhibitor Use and Mortality in COVID-19 Patients With Diabetes Mellitus: An Updated Systematic Review and Meta-analysis." Ther Adv Endocrinol Metab 2021.